Shao, Zhili
Richie, William D.
Bailey, Rahn Kennedy
Funding for this research was provided by:
Substance Abuse and Mental Health Services Administration
State of Tennessee Dept of Mental helath and Substance Abuse Services
American Psychiatric Association
Tennessee Psychiatric Association
National Medical Association
Article History
Received: 28 July 2015
Revised: 8 November 2015
Accepted: 12 November 2015
First Online: 16 December 2015
Compliance with Ethical Standards
:
: This work was supported by Health Disparities Research Center at Meharry, NIH/NIMHD grant P20MD000515 and Department of Health and Human Services/Human Resources and Services Administration grant D55HP23199.
: Dr. Bailey was supported by grants from the Substance Abuse and Mental Health Services Administration, State of Tennessee Department of Mental Health and Substance Abuse Services, American Psychiatric Association, Tennessee Psychiatric Association, and National Medical Association. Dr. Bailey also received funding from several pharmaceutical companies: Jannssen, Sunovion, and McMerl. Drs. Bailey, Richie and Shao were previously supported by a writing collaborative project in Health Disparities Research Center at Meharry, which was partly funded by the grants from NIH/NIMHD and US Department of Health and Human Services.